Foster P A
Blood Research Institute, Blood Center of Southeastern Wisconsin, Milwaukee 53201-2178, USA.
Thromb Haemost. 1995 Aug;74(2):784-90.
An international registry was established on the reproductive health of women with types of von Willebrand disease (vWd) unresponsive to DDAVP. Data was collected on 44 women from 16 treatment centers in nine countries. Severe menorrhagia requiring blood product therapy occurred at least once in 80% of the women for whom data was reported. Most of the reported episodes occurred prior to the diagnosis of vWd and/or the use of oral contraceptive (OC) therapy. OC therapy was clinically effective in the treatment of chronic menorrhagia in 22 of 25 (88%) women treated. Two of the women, however, were unable to tolerate chronic OC use and a third became refractory to treatment. Hysterectomy was performed in 10 of the 44 women (23%). The reported indication for six of the procedures was menorrhagia. Seventy percent were performed at two treatment centers, suggesting different thresholds for the performance of the procedure. There were 69 pregnancies reported in 31 of the 44 women. Fifteen of the pregnancies resulted in spontaneous abortions. The incidence of miscarriage was 22% and appeared clustered, with 10 of 15 of the miscarriages occurring in just four of the women.
建立了一个国际登记处,用于记录对去氨加压素无反应的血管性血友病(vWd)类型女性的生殖健康情况。收集了来自9个国家16个治疗中心的44名女性的数据。在报告数据的女性中,80%至少有一次发生严重月经过多,需要血液制品治疗。大多数报告的发作发生在vWd诊断之前和/或口服避孕药(OC)治疗使用之前。在接受治疗的25名女性中,有22名(88%)使用OC治疗慢性月经过多临床有效。然而,其中两名女性无法耐受长期使用OC,第三名女性对治疗产生了耐药性。44名女性中有10名(23%)接受了子宫切除术。报告的10例手术中有6例的指征是月经过多。70%的手术在两个治疗中心进行,这表明该手术的实施阈值不同。44名女性中有31名报告了69次怀孕。其中15次怀孕导致自然流产。流产发生率为22%,且似乎集中发生,15次流产中有10次仅发生在4名女性身上。